NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/14/2025
Back to search
Official data from USPTO
ADRENALINE DRIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ADRENALINE DRIVE
ST13
US500000087245670Class
5
Filing
87245670
Registration
5661994
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
02/14/2025
Trademark type
Word
Nice classes
5
Filing date
11/22/2016
Registration date
01/22/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/14/2025
Last transaction
02/14/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2018-01-00
First use in commerce
07/05/2018
Drawing code
4
Owner type
16
Owner location
WEST CALDWELL, NJ
Examiner
LE, KHANH M
Current location
Historical data usage
Holders and representatives
Holders
MAXIMUM HUMAN PERFORMANCE LLC
Prescott Ventures LLC
Representatives
Alison M. Caless Cantor Colburn LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vitamin supplements
Publications
History of USPTO decisions and trademark events.
43 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/14/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/14/2025
E815
TEAS SECTION 8 & 15 RECEIVED
10/07/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/22/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/22/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/18/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/17/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/08/2018
IUAF
USE AMENDMENT FILED
12/07/2018
EISU
TEAS STATEMENT OF USE RECEIVED
12/07/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/30/2018
EX2G
SOU EXTENSION 2 GRANTED
06/28/2018
EXT2
SOU EXTENSION 2 FILED
06/28/2018
EEXT
SOU TEAS EXTENSION RECEIVED
06/28/2018
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
05/07/2018
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
05/07/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/17/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/12/2018
EX1G
SOU EXTENSION 1 GRANTED
01/11/2018
NREV
NOTICE OF REVIVAL - E-MAILED
01/09/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
01/09/2018
PETG
PETITION TO REVIVE-GRANTED
01/09/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
01/09/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/05/2018
EXT1
SOU EXTENSION 1 FILED
01/04/2018
EEXT
SOU TEAS EXTENSION RECEIVED
01/02/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/09/2017
PUBO
PUBLISHED FOR OPPOSITION
05/09/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/19/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/07/2017
GNRT
NON-FINAL ACTION E-MAILED
03/07/2017
CNRT
NON-FINAL ACTION WRITTEN
03/07/2017
DOCK
ASSIGNED TO EXAMINER
02/28/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/30/2016
NWAP
NEW APPLICATION ENTERED
11/25/2016
Continuous trademark protection
Get notified about every new filing that threatens ADRENALINE DRIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.